Javascript must be enabled to continue!
Chloroquine embryotoxicity in the postimplantation rat conceptus in vitro
View through CrossRef
AbstractThe embryotoxicity of the antimalarial drug chloroquine (CQ) was evaluated in vitro using the rat whole embryo culture system. CQ was found to be embryotoxic and dysmorphogenic when added directly to the culture media containing gestational day (GD) 10 rat conceptuses. Twenty‐six‐hr exposure to CQ elicited dose‐related decreases in embryonic crown‐rump length, protein and DNA contents and increases in the incidence of morphologically abnormal embryos. At 30 μM CQ, embryonic protein content was decreased to 67% and DNA content to 58% of control while the incidence of morphological abnormalities rose to 100%. Abnormal axial rotation, microophthalmia, and selective cephalic hypoplasia were the most common developmental abnormalities observed. Visceral yolk sac (VYS) vasculature and blood pigmentation were also decreased in a dose‐dependent manner, as was VYS DNA content (80% of control at 30 μM). VYS protein content, however, showed an alternate pattern of response, decreasing to 87% of control at 10 μM CQ but increasing to 125% of control at 30 μM. Histologic evaluation revealed that the cytoplasm of the VYS endoderm epithelium was distended due to vacuolization produced by CQ exposure. In the embryo proper, CQ inhibited cranial neural tube development and altered the morphology of cranial neural crest cells. These observations document the in vitro embryotoxicity of CQ and suggest altered VYS histiotrophic nutrition as well as direct embryonic effects as possible mechanisms of CQ embryotoxicity. © 1993 Wiley‐Liss, Inc.
Title: Chloroquine embryotoxicity in the postimplantation rat conceptus in vitro
Description:
AbstractThe embryotoxicity of the antimalarial drug chloroquine (CQ) was evaluated in vitro using the rat whole embryo culture system.
CQ was found to be embryotoxic and dysmorphogenic when added directly to the culture media containing gestational day (GD) 10 rat conceptuses.
Twenty‐six‐hr exposure to CQ elicited dose‐related decreases in embryonic crown‐rump length, protein and DNA contents and increases in the incidence of morphologically abnormal embryos.
At 30 μM CQ, embryonic protein content was decreased to 67% and DNA content to 58% of control while the incidence of morphological abnormalities rose to 100%.
Abnormal axial rotation, microophthalmia, and selective cephalic hypoplasia were the most common developmental abnormalities observed.
Visceral yolk sac (VYS) vasculature and blood pigmentation were also decreased in a dose‐dependent manner, as was VYS DNA content (80% of control at 30 μM).
VYS protein content, however, showed an alternate pattern of response, decreasing to 87% of control at 10 μM CQ but increasing to 125% of control at 30 μM.
Histologic evaluation revealed that the cytoplasm of the VYS endoderm epithelium was distended due to vacuolization produced by CQ exposure.
In the embryo proper, CQ inhibited cranial neural tube development and altered the morphology of cranial neural crest cells.
These observations document the in vitro embryotoxicity of CQ and suggest altered VYS histiotrophic nutrition as well as direct embryonic effects as possible mechanisms of CQ embryotoxicity.
© 1993 Wiley‐Liss, Inc.
Related Results
Plasmodium vivax trophozoites insensitive to chloroquine
Plasmodium vivax trophozoites insensitive to chloroquine
AbstractBackgroundPlasmodium vivaxis a major cause of malaria and is still primarily treated with chloroquine. Chloroquine inhibits the polymerization of haem to inert haemozoin. F...
Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitro
Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitro
AbstractThe intercalating agent, m‐AMSA, and the epipodophyllotoxin, VP‐16, both topoisomerase II—reactive anticancer agents, are also embryotoxic agents in rat embryos cultured in...
Long cryopreserved lab-adapted Plasmodium falciparum increases resistance to chloroquine but not its susceptibility
Long cryopreserved lab-adapted Plasmodium falciparum increases resistance to chloroquine but not its susceptibility
Introduction: Plasmodium falciparum (P. falciparum) is a deadly protozoan that is accountable for malaria and chloroquine was the first-line antimalarial drug before its withdrawal...
Companion diagnostic for the chloroquine use in the treatment of COVID-19: systems biology report of candidate markers.
Companion diagnostic for the chloroquine use in the treatment of COVID-19: systems biology report of candidate markers.
Abstract
BACKGROUND
Chloroquine is used for the treatment of COVID-19 patients. However, efficacy of the chloroquine has been under discussion. Variability of clinical out...
Chloroquine use in the Treatment of COVID-19: Systems Biology Report of Common Targets of SARS-CoV-2 and Chloroquine.
Chloroquine use in the Treatment of COVID-19: Systems Biology Report of Common Targets of SARS-CoV-2 and Chloroquine.
Abstract
BACKGROUND: Chloroquine use for treatment of COVID-19 patients has been under discussion and recommendations have been shifting from positive to caution or non-con...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...
ANTI-PLASMODIAL EFFECT OF NICOTINAMIDE- VITAMIN B3 AGAINST CHLOROQUINE RESISTANT MALARIA IN AN IN VIVO MODEL
ANTI-PLASMODIAL EFFECT OF NICOTINAMIDE- VITAMIN B3 AGAINST CHLOROQUINE RESISTANT MALARIA IN AN IN VIVO MODEL
Nicotinamide (NICO), an amide derivative of nicotinic acid, used in high doses for four decades, has shown antimicrobial and potential anti-malarial activity in vitro. However, its...

